Nuvalent, Inc.
NUVLDelisted Jul 15, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001861560
Nuvalent, Inc. was delisted on Jul 15, 2026; its insiders filed their last Form 4 on Jul 17, 2026; 292 institutions reported holding it in 13F filings for Q2 2026, worth $9.29B in total; Soros Fund Management was the only superinvestor holding it.
Q2 2023 vs. Q1 2023
How the institutions holding Nuvalent, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 89 | 111 | +22 |
| Shares | 54.2M | 55.3M | +1.09M (+2.0%) |
| Value | $1.41B | $2.33B | +$920.0M (+65.2%) |
New holders (30)
Institutions that held Nuvalent, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
Sold out (8)
Institutions that held Nuvalent, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 57,633 | $1.50M |
| AlphaCentric Advisors LLC | 17,897 | $466.9K |
| Renaissance Technologies LLC | 17,300 | $451.0K |
| Cubist Systematic Strategies, LLC | 9,441 | $246.3K |
| Bailard, Inc. | 8,982 | $234.3K |
| Sandia Investment Management LP | 4,000 | $104.4K |
| Quantbot Technologies LP | 2,095 | $54.7K |
| Envestnet Asset Management Inc | 83,697 | $3.21K |